BiotechTube
PBS Biotech

PBS Biotech

Camarillo, United States· Est.
pbsbiotech.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $20M

Overview

PBS Biotech is a private company providing specialized bioreactor systems for the cell and gene therapy industry. Its core technology is the Vertical-Wheel bioreactor, which offers gentle, scalable mixing for sensitive therapeutic cells from small-scale development to commercial manufacturing. The company targets the growing biologics and cell therapy sectors, enabling customers to reduce costs and improve yields compared to traditional stirred-tank bioreactors.

OncologyRegenerative MedicineCardiovascularMetabolic Disease

Technology Platform

Vertical-Wheel single-use bioreactor systems designed for gentle, scalable mixing of shear-sensitive therapeutic cells (e.g., stem cells, CAR-T/NK cells) from 0.1L to 80L.

Funding History

2
Total raised:$20M
Series B$15M
Series A$5M

Opportunities

The rapid growth of the cell and gene therapy market, particularly the shift towards allogeneic (off-the-shelf) therapies requiring large-scale manufacturing, creates strong demand for scalable, single-use bioreactor solutions.
The company's technology addresses a key bottleneck in gentle, linear scale-up, positioning it well to capture market share from traditional stirred-tank systems.

Risk Factors

Intense competition from large, established bioprocess equipment vendors with broader product portfolios and greater sales reach.
Adoption risk as customers may be hesitant to switch from industry-standard stirred-tank platforms to a novel bioreactor design, requiring significant validation efforts.

Competitive Landscape

PBS Biotech competes in the single-use bioreactor market against major players like Cytiva (Xcellerex), Sartorius, Thermo Fisher Scientific, and Merck Millipore. Its differentiation is its specialized Vertical-Wheel technology optimized for shear-sensitive cell therapy applications, whereas competitors often offer more generalized stirred-tank designs adapted from microbial and CHO cell culture.

More companies in Cell & Gene Therapy →More companies in United States →